Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
伊匹木单抗联合地西他滨用于移植后或未移植的MDS或AML患者
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022017686
Garcia, Jacqueline S; Flamand, Yael; Penter, Livius; Keng, Michael; Tomlinson, Benjamin K; Mendez, Lourdes M; Koller, Paul; Cullen, Nicole; Arihara, Yohei; Pfaff, Kathleen; Wolff, Jacquelyn O; Brunner, Andrew M; Galinsky, Ilene; Bashey, Asad; Antin, Joseph H; Cutler, Corey; Ho, Vincent; Jonas, Brian A; Luskin, Marlise R; Wadleigh, Martha; Winer, Eric S; Savell, Alexandra; Leonard, Rebecca; Robertson, Taylor; Davids, Matthew S; Streicher, Howard; Rodig, Scott J; Ritz, Jerome; Wu, Catherine J; DeAngelo, Daniel J; Neuberg, Donna; Stone, Richard M; Soiffer, Robert J